pyridoxamine has been researched along with Diabetic Angiopathies in 4 studies
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelen, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Yamagishi, S | 1 |
| Imaizumi, T | 1 |
| Thomas, MC | 1 |
| Baynes, JW | 1 |
| Thorpe, SR | 1 |
| Cooper, ME | 1 |
| Cameron, NE | 1 |
| Gibson, TM | 1 |
| Nangle, MR | 1 |
| Cotter, MA | 1 |
4 reviews available for pyridoxamine and Diabetic Angiopathies
| Article | Year |
|---|---|
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2013 |
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Produc | 2005 |
The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.
Topics: Animals; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Humans; Ligands; Oxida | 2005 |
Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Glycation En | 2005 |